Home

Alivus Life Sciences Ltd 52 Week Low

Image

Alivus Life Sciences Ltd

NSE: ALIVUS

YEARLOW

₹ 666.05

Last updated on: Feb 05, 2025

Key Highlights

  • The 52 Week Low of Alivus Life Sciences Ltd is ₹ 666.05 as of 05 Feb 25 .

Company Fundamentals for Alivus Life Sciences Ltd

Market Price of Alivus Life Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Alivus Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
05 Feb 20251226.65
04 Feb 20251215.4
03 Feb 20251175.05
01 Feb 20251154.6
31 Jan 20251202
30 Jan 20251168.3
29 Jan 20251158.4
28 Jan 20251156.85
27 Jan 20251197.35
24 Jan 20251151.35

Asset Value vs Market Value of Alivus Life Sciences Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Historical Revenue of Alivus Life Sciences Ltd

No data available

* All values are in crore

Historical Net Profit of Alivus Life Sciences Ltd

No data available

* All values are in crore

Alivus Life Sciences Ltd News Hub

Glenmark Life Sciences Ltd leads gainers in 'A' group

Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are among the oth

Read more

05 Aug 24

Glenmark Life Sciences AGM scheduled

Glenmark Life Sciences announced that the Annual General Meeting (AGM) of the company will be held o

Read more

06 Sept 24

Glenmark Life drops after PAT slides 20% YoY to Rs 95 crore in Q2

Profit before tax (PBT) dropped 19.8% YoY to Rs 127.46 crore in the quarter ended 30 September 2024.

Read more

25 Oct 24

Glenmark Life Sciences standalone net profit declines 19.72% in the September 2024 quarter

Net profit of Glenmark Life Sciences declined 19.72% to Rs 95.32 crore in the quarter ended Septembe

Read more

25 Oct 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Alivus Life Sciences Ltd

Why is it important to track the 52-week low of Alivus Life Sciences Ltd stocks?

Investors should monitor the 52-week low of Alivus Life Sciences Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Alivus Life Sciences Ltd stocks hitting a 52-week low?

Factors leading to Alivus Life Sciences Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Alivus Life Sciences Ltd stocks when they hit a 52-week low?

Buying Alivus Life Sciences Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Alivus Life Sciences Ltd stocks?

Investors should monitor the 52-week low of Alivus Life Sciences Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Alivus Life Sciences Ltd stock at their 52-week low?

An investor can analyze the reasons for the Alivus Life Sciences Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Alivus Life Sciences Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Alivus Life Sciences Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Alivus Life Sciences Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions